The Preformulation focus group was established in 1993 to bring together all AAPS members with a common interest in the broad area of preformulation research. Preformulation research involves the characterization of physical and chemical properties of both small- and large-molecule drug substances or drug products and is performed at both the early- and mid-stage development in pharmaceutical development and manufacturing. Preformulation research helps to define the ingredients needed in a pharmaceutical formulation to achieve a desired product profile. The ultimate goal of the group is to provide a forum for exchange of ideas and development of strategies, which improve our capabilities in this important area of research applied to both small and large molecules.
- Provide a forum for information exchange of issues and advancements relating to solid, suspension and liquid-state characterization of chemical entities, active pharmaceutical ingredient, drug substance, excipients, and early phase development of pharmaceutical dosage forms and delivery systems.
- Promote and disseminate novel scientific advances in Preformulation in the areas of discovery and development of drug substance and drug product through themed meetings and workshops in PPB, FDD, and BIOTEC sections.
- Encourage and promote joint programs with other focus groups, academia and regulatory agencies e.g., Food and Drug Administration, U.S. Pharmacopeia, and other national regulatory agencies worldwide.
- Strengthen the membership through different portals such as the focus group newsletters, student chapters, conferences, volunteer activities, and AAPS listserve.
- Support nominations of preformulation scientists for AAPS awards.
Section affiliations: BIOTEC | FDD | PPB